Advancing Research in Myasthenia Gravis With Clinician-Patient Partnership: Richard Nowak, MD, MS
The assistant professor of neurology at the Yale School of Medicine spoke about the strength in the patient-clinician relationship in ensuring quality care for myasthenia gravis. [WATCH TIME: 4 minutes]
WATCH TIME: 4 minutes
“I think that all our patients are partners, in their own care and partners in research. Without them, we can't do any clinical research, and we can't advance the field.”
In the clinical community between clinicians and patients, there is a shared process in providing data and working towards new treatments. The partnership between both is important in that it helps patients adhere to treatment and allows clinicians to have a better perspective of the disease. It is essentially critical in diseases such as myasthenia gravis (MG), a patient population that has a prevalence of approximately 14-40 per 100,000, for there to be a working partnership with clinicians and patients to continue research in efforts for improved care outcomes.
In recent news, the Myasthenia Gravis Foundation of America (MGFA) re-launched its MGFA Global MG Patient Registry which allows patients with MG to submit their health data online. The registry is a secure portal for researchers to not only have a better understanding of the disease biology, but also to use the data for new studies to improve patient outcomes, and potentially for the development of new treatments for MG.1
Recently,
REFERENCES
1. Myasthenia Gravis Foundation of America (MGFA) Re-launches the MGFA Global MG Patient Registry with Partner Alira Health. News release. Myasthenia Gravis Foundation of America. Published January 25, 2023. Accessed February 16, 2023. https://myasthenia.org/Portals/0/News_Release_MGFA_Alira_Health_Partner_Final_1-25-2023_v2_1.pdf
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
- Current Challenges and New Opportunities Ahead for Women in Neurology
September 15th 2025
- Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
September 15th 2025
- 2025 Women in Neurology Conference: Educating, Mentoring, and Networking
September 15th 2025
- This Week on NeurologyLive® — September 15, 2025
September 15th 2025